Clinical Study
Gastric Cancer in the Young: Is It a Different Clinical Entity? A Retrospective Cohort Study
Table 1
Characteristics and preoperative abnormalities of patients with gastric cancer.
| | Parameter | Patients
<50 years
(20) | Patients
≥50 years
(112) | |
| | Age (years), mean ± SD | | | 0.000 | | Range | 27–49 | 50–87 | | | Median | 48 | 70 | | | Sex: female (%) | 12 (60.0%) | 49 (43.7%) | 0.272 | | Anemia: hemoglobin < 10 g/dL | 3 (15.0%) | 23 (20.5%) | 0.789 | | Hypoalbuminemia < 3.5 g/dL | 5 (25.0%) | 50 (44.6%) | 0.163 | | Comorbidities | | | | | Cardiac disease | 0 (0%) | 17 (15.2%) | 0.132 | | Hypertension | 3 (15.0%) | 38 (34.0%) | 0.155 | | Previous stroke | 0 (0%) | 8 (7.1%) | 0.469 | | Chronic obstructive pulmonary disease | 1 (5.6%) | 15 (13.4%) | 0.492 | | Diabetes mellitus | 0 (0%) | 7 (6.2%) | 0.544 | | Cirrhosis | 0 (0%) | 4 (3.6%) | 0.881 | | Number of concomitant disease | | | | | 0 | 15 (75.0%) | 54 (48.2%) | 0.049 | | 1 | 4 (20.0%) | 34 (30.4%) | | 2 | 1 (5.0%) | 17 (15.2%) | | 3 | 0 (0%) | 7 (6.2%) | | ASA score | | | | | I-II | 19 (95.0%) | 75 (67.0%) | 0.022 | | III-IV | 1 (5.0%) | 37 (33.0%) | | BMI (body mass index) | | | 0.242 | | Median | 22 | 24 | | Symptoms | | | | | Epigastric pain | 12 (60.0%) | 75 (67.0%) | 0.727 | | Vomiting | 3 (15.0%) | 9 (8.0%) | 0.565 | | Dysphagia | 2 (10.0%) | 14 (12.5%) | 0.955 | | Fatigue | 6 (30.0%) | 41 (36.6%) | 0.552 | | Loss of appetite | 6 (30.0%) | 28 (25.0%) | 0.847 | | Sarcophobia | 3 (15.0%) | 10 (8.9%) | 0.666 | | Upper gastrointestinal bleeding | 1 (5.0%) | 8 (7.2%) | 0.896 | | Weight loss | 6 (30.0%) | 66 (58.9%) | 0.032 | | Duration of symptoms (months) mean ± SD | | | | | Median | 10 | 5 | 0.030 | | History of peptic ulcer | 1 (5.0%) | 3 (2.7%) | 0.876 | | Family history of gastric cancer | 1 (5.0%) | 7 (6.2%) | 0.770 | | Helicobacter pylori infection | 5 (25.0%) | 6 (5.4%) | 0.013 |
|
|
SD: standard deviation; ASA: American Society of Anesthesiology; BMI: body mass index; values are bilateral.
|
